Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Morgan

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
Gastroenterology|May 26, 2012
Factors that predict response of patients with hepatitis C virus infection to boceprevirFred Poordad, Jean-Pierre Bronowicki, Stuart C Gordon, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis CJules L Dienstag, Marc G Ghany, Timothy R Morgan, et al.
Alcoholism, Clinical and Experimental Research|April 16, 2015
Brief report: genetics of alcoholic cirrhosis-GenomALC multinational studyJohn B Whitfield, Khairunnessa Rahman, Paul S Haber, et al.
Implementation Science : IS|December 13, 2025
Getting to Implementation: applying data-driven implementation strategies to improve guideline concordant surveillance for hepatocellular carcinomaVera Yakovchenko, Chaeryon Kang, Brittney Neely, et al.
Annals of Hepatology|October 15, 2016
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infectionMaribel Rodriguez-Torres, Eric Lawitz, Bienvenido Yangco, et al.
Nature Genetics|January 8, 2013
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusLudmila Prokunina-Olsson, Brian Muchmore, Wei Tang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 17, 2023
Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement ProjectShari S Rogal, Tamar H Taddei, Alexander Monto, et al.
Hepatology (Baltimore, Md.)|May 13, 2009
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trialTania Mara Welzel, Timothy R Morgan, Herbert L Bonkovsky, et al.
The American Journal of Gastroenterology|August 10, 2005
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infectionEdmund J Bini, Norbert Bräu, Sue Currie, et al.
The American Journal of Pathology|May 12, 2026
SIRPa cleavage is associated with inflammatory response, corticosteroid non-response, and worse prognosis in clinical and pre-clinical models of alcohol-associated hepatitisEthan R Steele, Dylan Nunn, David Malicote, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Gastroenterology|May 26, 2012
Factors that predict response of patients with hepatitis C virus infection to boceprevirFred Poordad, Jean-Pierre Bronowicki, Stuart C Gordon, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis CJules L Dienstag, Marc G Ghany, Timothy R Morgan, et al.
Alcoholism, Clinical and Experimental Research|April 16, 2015
Brief report: genetics of alcoholic cirrhosis-GenomALC multinational studyJohn B Whitfield, Khairunnessa Rahman, Paul S Haber, et al.
Implementation Science : IS|December 13, 2025
Getting to Implementation: applying data-driven implementation strategies to improve guideline concordant surveillance for hepatocellular carcinomaVera Yakovchenko, Chaeryon Kang, Brittney Neely, et al.
Annals of Hepatology|October 15, 2016
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infectionMaribel Rodriguez-Torres, Eric Lawitz, Bienvenido Yangco, et al.
Nature Genetics|January 8, 2013
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusLudmila Prokunina-Olsson, Brian Muchmore, Wei Tang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 17, 2023
Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement ProjectShari S Rogal, Tamar H Taddei, Alexander Monto, et al.
Hepatology (Baltimore, Md.)|May 13, 2009
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trialTania Mara Welzel, Timothy R Morgan, Herbert L Bonkovsky, et al.
The American Journal of Gastroenterology|August 10, 2005
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infectionEdmund J Bini, Norbert Bräu, Sue Currie, et al.
The American Journal of Pathology|May 12, 2026
SIRPa cleavage is associated with inflammatory response, corticosteroid non-response, and worse prognosis in clinical and pre-clinical models of alcohol-associated hepatitisEthan R Steele, Dylan Nunn, David Malicote, et al.
Pageof 18